<?xml version="1.0" encoding="iso-8859-1" standalone="no"?>
<GmsArticle>
  <MetaData>
    <Identifier>000080</Identifier>
    <IdentifierDoi>10.3205/000080</IdentifierDoi>
    <IdentifierUrn>urn:nbn:de:0183-0000807</IdentifierUrn>
    <ArticleType>Review Article</ArticleType>
    <TitleGroup>
      <Title language="en">Water, electrolytes, vitamins and trace elements &#8211; Guidelines on Parenteral Nutrition, Chapter 7</Title>
      <TitleTranslated language="de">Wasser, Elektrolyte, Vitamine und Spurenelemente &#8211; Leitlinie Parenterale Ern&#228;hrung, Kapitel 7</TitleTranslated>
    </TitleGroup>
    <CreatorList>
      <Creator>
        <PersonNames>
          <Lastname>Biesalski</Lastname>
          <LastnameHeading>Biesalski</LastnameHeading>
          <Firstname>H. K.</Firstname>
          <Initials>HK</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Institute for Biochemistry und Nutrition Science, University of Stuttgart-Hohenheim, Germany</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Bischoff</Lastname>
          <LastnameHeading>Bischoff</LastnameHeading>
          <Firstname>S. C.</Firstname>
          <Initials>SC</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Dept Nutritional Medicine and Prevention, University Stuttgart-Hohenheim, Germany</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Boehles</Lastname>
          <LastnameHeading>Boehles</LastnameHeading>
          <Firstname>H. J.</Firstname>
          <Initials>HJ</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Dept. of Paediatrics, Johann-Wolfgang-Goethe University of Frankfurt, Germany</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Lastname>Muehlhoefer</Lastname>
          <LastnameHeading>Muehlhoefer</LastnameHeading>
          <Firstname>A.</Firstname>
          <Initials>A</Initials>
        </PersonNames>
        <Address>
          <Affiliation>Dept. of Internal Medicine, Gastroenterology, Hepatology and Infectiology, St. Catharine&#39;s Hospital, Stuttgart, Germany</Affiliation>
        </Address>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
      <Creator>
        <PersonNames>
          <Corporation>
            <Corporatename>Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine</Corporatename>
            <CorporateHeading>Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine</CorporateHeading>
          </Corporation>
        </PersonNames>
        <Creatorrole corresponding="no" presenting="no">author</Creatorrole>
      </Creator>
    </CreatorList>
    <PublisherList>
      <Publisher>
        <Corporation>
          <Corporatename>German Medical Science GMS Publishing House</Corporatename>
        </Corporation>
        <Address>D&#252;sseldorf</Address>
      </Publisher>
    </PublisherList>
    <SubjectGroup>
      <SubjectheadingDDB>610</SubjectheadingDDB>
      <Keyword language="en">fluid intake</Keyword>
      <Keyword language="en">trace elements</Keyword>
      <Keyword language="en">zinc</Keyword>
      <Keyword language="en">selenium</Keyword>
      <Keyword language="en">vitamins</Keyword>
      <Keyword language="de">Fl&#252;ssigkeitsaufnahme</Keyword>
      <Keyword language="de">Spurenelemente</Keyword>
      <Keyword language="de">Zink</Keyword>
      <Keyword language="de">Selen</Keyword>
      <Keyword language="de">Vitamine</Keyword>
      <SectionHeading language="en">Special Issue</SectionHeading>
    </SubjectGroup>
    <DateReceived>20090114</DateReceived>
    <DatePublishedList>
      <DatePublished>20091118</DatePublished>
    </DatePublishedList>
    <Language>engl</Language>
    <SourceGroup>
      <Journal>
        <ISSN>1612-3174</ISSN>
        <Volume>7</Volume>
        <JournalTitle>GMS German Medical Science</JournalTitle>
        <JournalTitleAbbr>GMS Ger Med Sci</JournalTitleAbbr>
      </Journal>
    </SourceGroup>
    <ArticleNo>21</ArticleNo>
  </MetaData>
  <OrigData>
    <Abstract language="de" linked="yes">
      <Pgraph>F&#252;r die Berechnung der Fl&#252;ssigkeitszufuhr bei parenteral ern&#228;hrten Patienten ist eine enge Absprache zwischen den betreuenden &#228;rztlichen Teams notwendig. Neben der PE muss auch die oral und enteral zugef&#252;hrte Fl&#252;ssigkeit sowie ggf. eine weitere Infusionstherapie und au&#223;ergew&#246;hnliche Fl&#252;ssigkeitsverluste (z.B. Diarrh&#246;e) ber&#252;cksichtigt werden. F&#252;r Patienten mit gest&#246;rtem Wasser- oder Elektrolythaushalt ist eine gezielte Diagnostik (Volumenstatus) zur Ermittlung des individuellen Fl&#252;ssigkeitsbedarfs erforderlich. W&#228;hrend der Fl&#252;ssigkeitsbedarf f&#252;r Erwachsene mit normalem Volumenstatus bei ca. 30&#8211;40 ml&#47;kg KG&#47;d liegt, ist der Fl&#252;ssigkeitsbedarf bei Fieber &#252;blicherweise erh&#246;ht. Bei normalem Fl&#252;ssigkeits- und Elektrolythaushalt erfolgt die Zufuhr von Elektrolyten initial standardisiert nach allgemeinen Empfehlungen. Die Serumelektrolytkonzentrationen sollten vor Beginn einer PE bestimmt werden. Eine Elektrolytzufuhr im Bereich des normalen Bedarfs wird mit der appliziert. Bei deutlich gesteigertem Bedarf sind zus&#228;tzliche Zufuhrwege (z.B. &#252;ber separate Infusionspumpen) sinnvoll. Die isolierte Zufuhr von hochdosierten Kalium- (1mval&#47;ml) bzw. NaCl 20&#37;-L&#246;sungen sollte &#252;ber einen zentralen Venenkatheter erfolgen. Die Elektrolytzufuhr muss im Verlauf der PE nach regelm&#228;&#223;ig durchgef&#252;hrten Laborkontrollen angepasst werden. Bei initial ver&#228;ndertem Elektrolythaushalt (z.B. bedingt durch chronische Diarrh&#246;e, rezidivierendes Erbrechen, Niereninsuffizienz etc.) ist eine individuelle angepasste Elektrolytzufuhr erforderlich. Vitamine und Spurenelemente sollten bei PE grunds&#228;tzlich substituiert werden, sofern keine Kontraindikationen bestehen. Ab einer P<TextGroup><PlainText>E-Da</PlainText></TextGroup>uer &#62;1 Woche ist die Supplementation von Vitaminen und Spurenelementen obligat. Die Zufuhr von Vitaminen und Spurenelementen in Anlehnung an Dosisempfehlungen f&#252;r die orale Ern&#228;hrung wird generell empfohlen falls nicht spezielle Krankheitssituationen andere Z<TextGroup><PlainText>ufuhre</PlainText></TextGroup>n erfordern.</Pgraph>
    </Abstract>
    <Abstract language="en" linked="yes">
      <Pgraph>A close cooperation between medical teams is necessary when calculating the fluid intake of parenterally fed patients. Fluids supplied parenterally, orally and enterally, other infusions, and additional fluid losses (e.g. diarrhea) must be considered. Targeted diagnostic monitoring (volume status) is required in patients with disturbed water or electrolyte balance. Fluid requirements of adults with normal hydration status is approximately 30&#8211;40 ml&#47;kg body weight&#47;d, but fluid needs usually increase during fever. Serum electrolyte concentrations should be determined prior to PN, and patients with normal fluid and electrolyte balance should receive intakes follwing standard recommendations with PN. Additional requirements should usually be administered via separate infusion pumps. Concentrated potassium (1 mval&#47;ml) or 20&#37; NaCl solutions should be infused via a central venous catheter. Electrolyte intake should be adjusted according to the results of regular laboratory analyses. Individual determination of electrolyte intake is required when electrolyte balance is initially altered (e.g. due to chronic diarrhea, recurring vomiting, renal insufficiency etc.). Vitamins and trace elements should be generally substituted in PN, unless there are contraindications. The supplementation of vitamins and trace elements is obligatory after a PN of &#62;1 week. A standard dosage of vitamins and trace elements based on current dietary reference intakes for oral feeding is generally recommended unless certain clinical situations require other intakes. </Pgraph>
    </Abstract>
    <TextBlock linked="yes" name="Preliminary remarks">
      <MainHeadline>Preliminary remarks</MainHeadline>
      <Pgraph>Fluid and electrolyte requirements, of patients receiving PN are administered by means of  parenteral infusions, oral and&#47;or enteral intake. A close cooperation is, therefore, necessary between medical teams, involved in the overall care of the patient and the team prescribing the PN intakes of the patient, especially if the teams are mutually exclusive.</Pgraph>
      <Pgraph>Many of the practices involved in providing fluid and electrolyte requirements of the patients, particularly the substitution of vitamins and trace elements, are clinically established practices that are not based on randomized studies. Some recent clinical studies evaluating high-dosage vitamins or trace elements are mostly prospective, controlled and randomised studies. Although these studies have the highest level of evidence (A), general recommendations cannot not always derived from these studies, because they usually included small patient numbers only. </Pgraph>
    </TextBlock>
    <TextBlock linked="yes" name="Fluid intake in parenteral nutrition">
      <MainHeadline>Fluid intake in parenteral nutrition</MainHeadline>
      <Pgraph>
        <UnorderedList>
          <ListItem level="1">The fluid requirement in adults with normal hydration status is approximately 30&#8211;40 ml&#47;kg body weight&#47;d. Depending on their age, children have a much higher fluid intake per kg body weight (cf. chapter &#8220;Neonatology&#47;Paediatrics&#8221;; <Hyperlink href="http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000074.shtml">http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000074.shtml</Hyperlink>) (C). </ListItem>
          <ListItem level="1">In the event of fever, fluid needs usually increase by approximately 10 ml&#47;kg body weight&#47;d per 1&#176;C rise in temperature above 37&#176;C (C).</ListItem>
          <ListItem level="1">Targeted diagnostic monitoring is required in patients with disturbed water or electrolyte balance (e.g. shock, sepsis, renal insufficiency) to determine individual fluid needs (C).</ListItem>
          <ListItem level="1">When calculating the fluid intake of parenterally fed patients, fluids supplied parenterally, orally and enterally, other infusions, and additional fluid losses (e.g. diarrhea) must be considered (C). </ListItem>
        </UnorderedList>
      </Pgraph>
      <SubHeadline>Commentary</SubHeadline>
      <Pgraph>The recommended daily fluid supplies are not based on systematic studies, but on clinical experience and recommendations by experts and medical societies <TextLink reference="1"></TextLink>. <TextLink reference="2"></TextLink>, <TextLink reference="3"></TextLink>, <TextLink reference="4"></TextLink>, <TextLink reference="5"></TextLink>. There is no conclusive literature on fluid requirements in patients with fever, or in patients with disturbed water or electrolyte balances. The recommendations made here are, therefore, based on expert opinion (C).  </Pgraph>
      <Pgraph>The determination of the hydration of a patient is a prerequisite for calculating parenteral fluid requirements, especially when a disturbance in fluid balance is clinically suspected. In such patients, transitions between hypovolaemia, euvolaemia and hypervolaemia are frequent. The current fluid volume status may be evaluated by clinical symptoms (change of body weight, skin turgor, central venous pressure (CVP), sonographic evidence of vena cava filling) and laboratory parameters (haematocrit, serum sodium, serum and urine osmolarity). Hypovolaemia is characterised by weight loss, reduced skin turgor, dry mucous membranes, reduced arterial and central venous pressure (collapsed jugular vein, CVP <TextGroup><PlainText>&#60;4 cm</PlainText></TextGroup> H<Subscript>2</Subscript>O, collapsed vena cava in sonography), tachycardia, and where applicable increased serum sodium and increased serum osmolarity as well as increased urine osmolarity (&#62;450 mosmol&#47;kg). Symptoms of hypervolaemia are typically the formation of edema, in the legs or on the coccyx in bedridden patients, pulmonary edema, ascites, a tendency towards arterial hypertension, and increased filling pressure in the large veins. Laboratory tests may also show reduced plasma osmolarity and hematocrit levels <TextLink reference="6"></TextLink>. These criteria usually allow for estimates of the current fluid volume status, both at the beginning of and during PN. Treatment of the underlying illness causing a fluid imbalance should also be initiated. Fluid imbalance can be symptomatically treated by means of individually adapted PN, for example, in critically ill patients and patients with acute or chronic renal, liver, heart or lung insufficiency. Strict monitoring of and appropriate changes in fluid and electrolyte intake are necessary in patients at-risk for disturbances in fluid and electrolyte balance, especially in critically ill patients and in patients with renal failure or chronic renal insufficiency (cf. chapter &#8220;Parenteral nutrition in patients with renal failure&#8221;; <Hyperlink href="http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000070.shtml">http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000070.shtml</Hyperlink>).</Pgraph>
    </TextBlock>
    <TextBlock linked="yes" name="Electrolyte intake in parenteral nutrition">
      <MainHeadline>Electrolyte intake in parenteral nutrition</MainHeadline>
      <Pgraph>
        <UnorderedList>
          <ListItem level="1">Electrolyte intake in patients with normal fluid and electrolyte balance should follow general recommendations (Table 1 <ImgLink imgNo="1" imgType="table"/>). Serum electrolyte concentrations (Na, K, Ca, Mg, phosphate) should generally be determined prior to commencing PN (C). </ListItem>
          <ListItem level="1">Electrolyte supplies in the normal range may be administered with the glucose-amino acid solution (C). Additional requirements should be administered by other methods (i.e. via separate infusion pumps), to avoid compatibility problems (C). Isolated potassium <TextGroup><PlainText>(1 mval&#47;ml)</PlainText></TextGroup> or 20&#37; NaCl should be infused via a central venous catheter (C).</ListItem>
          <ListItem level="1">Electrolyte intake should be adjusted according to the results of regular laboratory analyses performed during PN. Individual determination of electrolyte intake is required when electrolyte balance is initially altered (e.g. due to chronic diarrhea, recurring vomiting, renal insufficiency etc.) (A).</ListItem>
        </UnorderedList>
      </Pgraph>
      <SubHeadline>Commentary</SubHeadline>
      <Pgraph>Electrolyte supply with PN is closely linked to fluid intake. The values for standard electrolyte intake (Table 1 <ImgLink imgNo="1" imgType="table"/>) have been adapted from the guidelines of the American Gastroenterological Association (AGA) <TextLink reference="5"></TextLink>, which are based on the &#8220;FDA Requirements for Marketing&#8221; published in 2000 <TextLink reference="7"></TextLink>. These values should be seen as general guidelines and may be used in patients with normal renal and liver functions as well as normal electrolyte concentrations in the blood. Restrictions may be necessary in disorders where limited intake is recommended, e.g. of sodium in hypertension and cardiac insufficiency. Currently available recommendations for standard electrolyte intake are based on oral intake and have been extrapolated for the parenteral situation. The requirement of laboratory checks at the beginning of PN is an expert opinion. When determining the electrolyte intake in PN, it should be taken into consideration that many commercially available multi-chamber bags and amino acid solutions contain electrolytes in various doses, which do not always meet patients&#8217; requirements in the long run. These quantities need to be taken into account when calculation additional needs that may need to be added to the PN bag. </Pgraph>
      <Pgraph>In case of a standard electrolyte intake, this should be administered via the PN bag (C). Higher doses may be required in the event of large fluid losses (e.g. vomiting, diarrhea, large wounds, high-output fistulae, renal illnesses). Such additional electrolytes should generally be given as a separate infusion, e.g. via infusion pumps, if requirements exceed the upper end of the ranges shown in Table 1<ImgLink imgNo="1" imgType="table"/>. Compatibility problems are thus prevented, and short-term adjustments in electrolyte levels are possible. </Pgraph>
      <Pgraph>There are no studies evaluating the adequate frequency of laboratory monitoring of serum electrolytes during PN. A check every 24 hours was found beneficial in intensive care patients at the beginning of PN (week 1&#8211;2), whilst twice weekly testing for ward patients was considered adequate as long as there were no special risk factors (8). The time intervals between tests might be extended with longer duration of PN, provided the electrolyte values were stable; checks every 1&#8211;2 weeks in the first three months, and then every month in the following three months generally are sufficient in stable patients on at-home parenteral nutrition <TextLink reference="8"></TextLink>. This recommendation is in agreement with the Mayo scheme, which is presented in more detail in the chapter on &#8220;Complications and monitoring&#8221;; <Hyperlink href="http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000076.shtml">http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000076.shtml</Hyperlink>. </Pgraph>
    </TextBlock>
    <TextBlock linked="yes" name="Supply of vitamins and trace elements during parenteral nutrition under standard conditions">
      <MainHeadline>Supply of vitamins and trace elements during parenteral nutrition under standard conditions</MainHeadline>
      <Pgraph>
        <UnorderedList>
          <ListItem level="1">Parenteral vitamins and trace element supplies should be provided to patients receiving total PN (C). </ListItem>
          <ListItem level="1">Vitamins and trace elements should be generally substituted in PN, unless there are contraindications. The supplementation of vitamins and trace elements is obligatory after a PN duration of &#62;1 week. </ListItem>
          <ListItem level="1">A standard dosage of vitamins and trace elements is generally recommended because individual requirements cannot be easily determined. Preferably, all vitamins and trace elements supplied with a normal diet should also be substituted with PN as available (C). The quantities of daily parenteral vitamin and trace element supplies are based on current dietary reference intakes for oral feeding (A). </ListItem>
        </UnorderedList>
      </Pgraph>
      <SubHeadline>Commentary</SubHeadline>
      <Pgraph>Vitamins and trace elements must be administered as essential nutrients to parenterally fed patients to prevent deficiency syndromes <TextLink reference="9"></TextLink>, <TextLink reference="10"></TextLink>, <TextLink reference="11"></TextLink>. There is a lack of studies clearly indicating when it is necessary to substitute vitamins and trace elements with PN. In patients who receive home PN, deficits have been shown to occur without substitution, and they can be completely or partially corrected with standard supplies <TextLink reference="9"></TextLink>, <TextLink reference="10"></TextLink>, <TextLink reference="11"></TextLink>. The supply of vitamin E reduces the formation of lipid peroxides during PN <TextLink reference="12"></TextLink>. </Pgraph>
      <Pgraph>The recommended standard supplies of vitamins and trace elements in adults (Table 2 <ImgLink imgNo="2" imgType="table"/>) have been adapted from the guidelines for electrolytes by the American Gastroenterological Association (AGA) and should be regarded as estimated requirements <TextLink reference="5"></TextLink>, which are based on the &#8220;FDA Requirements for Marketing&#8221; from 2000 <TextLink reference="7"></TextLink>. They do not completely correspond to the reference intake values for healthy, orally fed subjects <TextLink reference="3"></TextLink>. Recommendations for parenteral trace element supply in children are provided (Table 3 <ImgLink imgNo="3" imgType="table"/>) <TextLink reference="13"></TextLink>, <TextLink reference="14"></TextLink>. While standardised vitamin supplementation does not result in desirable blood or tissue concentrations for all vitamins <TextLink reference="15"></TextLink>, <TextLink reference="16"></TextLink>, it is not possible to determine individual requirements of vitamin and trace elements with clinical routine care.</Pgraph>
      <Pgraph>Vitamins and trace elements should be added to the parenteral solutions. Vitamins should be added just before using the nutrition bag. Loss of activity can be minimized by dissolving the vitamins in a lipid solution or by using a light protection covering <TextLink reference="17"></TextLink> (cf. chapter &#8220;Practical Handling of AIO Admixtures&#8221;; <Hyperlink href="http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000077.shtml">http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000077.shtml</Hyperlink>).</Pgraph>
      <SubHeadline>Guidelines on the deviation from standard conditions in the substitution of vitamins and trace elements</SubHeadline>
      <Pgraph>
        <UnorderedList>
          <ListItem level="1">A deviation from the standard intake of vitamins and trace elements may be indicated under certain clinical situations (C). </ListItem>
        </UnorderedList>
      </Pgraph>
      <SubHeadline>Commentary</SubHeadline>
      <Pgraph>A standard supplementation of micronutrients may not be sufficient for certain medical situations, for instance, in bone marrow transplants <TextLink reference="18"></TextLink> and in dialysis patients (cf. chapter &#8220;Parenteral nutrition in patients with renal failure&#8221;; <Hyperlink href="http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000070.shtml">http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000070.shtml</Hyperlink>). There are studies where pharmacological doses of certain vitamins and trace elements were used. It was shown that low plasma concentrations of vitamin C could be normalised after administration of high doses of vitamin C in perioperative intensive care patients <TextLink reference="19"></TextLink>. The use of pharmacological doses of specific micronutrients exceeds the requirements of PN and therefore, will not be discussed here (Table 4 <ImgLink imgNo="4" imgType="table"/>).</Pgraph>
      <Pgraph>An up-to-date overview of the vitamins and trace elements supplements presently available for parenteral use in Germany is provided (Table 5 <ImgLink imgNo="5" imgType="table"/> and Table 6 <ImgLink imgNo="6" imgType="table"/>). These supplements can be used in daily clinical practice, even though the composition of these supplements does not correspond exactly to the estimated vitamin requirements (<TextGroup><PlainText>Table 2 </PlainText></TextGroup><ImgLink imgNo="2" imgType="table"/><TextGroup><PlainText>). </PlainText></TextGroup></Pgraph>
    </TextBlock>
    <TextBlock linked="yes" name="Notes">
      <MainHeadline>Notes</MainHeadline>
      <Pgraph>This article is part of the publication of the Guidelines on Parenteral Nutrition from the German Society for Nutritional Medicine (overview and corresponding address under <Hyperlink href="http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000086.shtml">http:&#47;&#47;www.egms.de&#47;en&#47;journals&#47;gms&#47;2009-7&#47;000086.shtml</Hyperlink>).</Pgraph>
      <Pgraph>English version edited by Sabine Verwied-Jorky, Rashmi Mittal and Berthold Koletzko, Univ. of Munich Medical Centre, Munich, Germany.</Pgraph>
    </TextBlock>
    <References linked="yes">
      <Reference refNo="1">
        <RefAuthor>ASPEN Board of Directors and the Clinical Guidelines Task Force</RefAuthor>
        <RefTitle>Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>JPEN J Parenter Enteral Nutr</RefJournal>
        <RefPage>1SA-138SA</RefPage>
        <RefTotal>ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26(1 Suppl):1SA-138SA.</RefTotal>
      </Reference>
      <Reference refNo="2">
        <RefAuthor>Bischoff SC</RefAuthor>
        <RefAuthor>Ockenga J</RefAuthor>
        <RefAuthor>Manns MP</RefAuthor>
        <RefTitle>K&#252;nstliche Ern&#228;hrung in der internistischen Intensivmedizin Chancen und Probleme &#91;Artificial nutrition in intensive internal medicine. Chances and problems&#93;</RefTitle>
        <RefYear>2000</RefYear>
        <RefJournal>Internist (Berl)</RefJournal>
        <RefPage>1041-61</RefPage>
        <RefTotal>Bischoff SC, Ockenga J, Manns MP. K&#252;nstliche Ern&#228;hrung in der internistischen Intensivmedizin Chancen und Probleme &#91;Artificial nutrition in intensive internal medicine. Chances and problems&#93;. Internist (Berl). 2000;41(10):1041-61. DOI: 10.1007&#47;s001080050663</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1007&#47;s001080050663</RefLink>
      </Reference>
      <Reference refNo="3">
        <RefAuthor>Deutsche Gesellschaft f&#252;r Ern&#228;hrung</RefAuthor>
        <RefTitle></RefTitle>
        <RefYear>2000</RefYear>
        <RefBookTitle>Referenzwerte f&#252;r die N&#228;hrstoffzufuhr &#91;Reference Values for Nutrient Intake&#93;</RefBookTitle>
        <RefPage></RefPage>
        <RefTotal>Deutsche Gesellschaft f&#252;r Ern&#228;hrung. Referenzwerte f&#252;r die N&#228;hrstoffzufuhr &#91;Reference Values for Nutrient Intake&#93;. Frankfurt am Main: Umschau-Braus-Verl.; 2000.</RefTotal>
      </Reference>
      <Reference refNo="4">
        <RefAuthor>Filston HC</RefAuthor>
        <RefTitle>Fluid and electrolyte management in the pediatric surgical patient</RefTitle>
        <RefYear>1992</RefYear>
        <RefJournal>Surg Clin North Am</RefJournal>
        <RefPage>1189-205</RefPage>
        <RefTotal>Filston HC. Fluid and electrolyte management in the pediatric surgical patient. Surg Clin North Am. 1992;72(6):1189-205.</RefTotal>
      </Reference>
      <Reference refNo="5">
        <RefAuthor>Koretz RL</RefAuthor>
        <RefAuthor>Lipman TO</RefAuthor>
        <RefAuthor>Klein S</RefAuthor>
        <RefTitle>AGA technical review on parenteral nutrition</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Gastroenterology</RefJournal>
        <RefPage>970-1001</RefPage>
        <RefTotal>Koretz RL, Lipman TO, Klein S. AGA technical review on parenteral nutrition. Gastroenterology. 2001;121:970-1001. DOI: 10.1016&#47;S0016-5085(01)92000-1</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1016&#47;S0016-5085(01)92000-1</RefLink>
      </Reference>
      <Reference refNo="6">
        <RefAuthor>Rose B</RefAuthor>
        <RefAuthor>Post T</RefAuthor>
        <RefTitle></RefTitle>
        <RefYear>2001</RefYear>
        <RefBookTitle>Clinical Physiology of acid-base and electrolyte disorders</RefBookTitle>
        <RefPage></RefPage>
        <RefTotal>Rose B, Post T. Clinical Physiology of acid-base and electrolyte disorders. New York: McGraw-Hill; 2001.</RefTotal>
      </Reference>
      <Reference refNo="7">
        <RefAuthor>Food and Drug Administration (FDA)</RefAuthor>
        <RefTitle>Parenteral Multivitamin Products; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment</RefTitle>
        <RefYear>2000</RefYear>
        <RefJournal>Federal Register</RefJournal>
        <RefPage>21200-1</RefPage>
        <RefTotal>Food and Drug Administration (FDA). Parenteral Multivitamin Products; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment. Federal Register. 2000;65:21200-1.</RefTotal>
      </Reference>
      <Reference refNo="8">
        <RefAuthor>Kelly DG</RefAuthor>
        <RefTitle>Guidelines and available products for parenteral vitamins and trace elements</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>JPEN J Parenter Enteral Nutr</RefJournal>
        <RefPage>S34-6</RefPage>
        <RefTotal>Kelly DG. Guidelines and available products for parenteral vitamins and trace elements. JPEN J Parenter Enteral Nutr. 2002;26(5 Suppl):S34-6.</RefTotal>
      </Reference>
      <Reference refNo="9">
        <RefAuthor>Davis AT</RefAuthor>
        <RefAuthor>Franz FP</RefAuthor>
        <RefAuthor>Courtnay DA</RefAuthor>
        <RefAuthor>Ullrey DE</RefAuthor>
        <RefAuthor>Scholten DJ</RefAuthor>
        <RefAuthor>Dean RE</RefAuthor>
        <RefTitle>Plasma vitamin and mineral status in home parenteral nutrition patients</RefTitle>
        <RefYear>1987</RefYear>
        <RefJournal>JPEN J Parenter Enteral Nutr</RefJournal>
        <RefPage>480-5</RefPage>
        <RefTotal>Davis AT, Franz FP, Courtnay DA, Ullrey DE, Scholten DJ, Dean RE. Plasma vitamin and mineral status in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1987;11(5):480-5. DOI: 10.1177&#47;0148607187011005480</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1177&#47;0148607187011005480</RefLink>
      </Reference>
      <Reference refNo="10">
        <RefAuthor>Labadarios D</RefAuthor>
        <RefAuthor>O&#39;Keefe SJ</RefAuthor>
        <RefAuthor>Dicker J</RefAuthor>
        <RefAuthor>Van Stuijvenberg L</RefAuthor>
        <RefAuthor>Visser L</RefAuthor>
        <RefAuthor>Louw ME</RefAuthor>
        <RefAuthor>Shephard GS</RefAuthor>
        <RefTitle>Plasma vitamin levels in patients on prolonged total parenteral nutrition</RefTitle>
        <RefYear>1988</RefYear>
        <RefJournal>JPEN J Parenter Enteral Nutr</RefJournal>
        <RefPage>205-11</RefPage>
        <RefTotal>Labadarios D, O&#39;Keefe SJ, Dicker J, Van Stuijvenberg L, Visser L, Louw ME, Shephard GS. Plasma vitamin levels in patients on prolonged total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1988;12(2):205-11. DOI: 10.1177&#47;0148607188012002205</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1177&#47;0148607188012002205</RefLink>
      </Reference>
      <Reference refNo="11">
        <RefAuthor>Marinier E</RefAuthor>
        <RefAuthor>Gorski AM</RefAuthor>
        <RefAuthor>de Courcy GP</RefAuthor>
        <RefAuthor>Criqui C</RefAuthor>
        <RefAuthor>Bunodiere M</RefAuthor>
        <RefAuthor>Christides JP</RefAuthor>
        <RefAuthor>Causse MB</RefAuthor>
        <RefAuthor>Brion F</RefAuthor>
        <RefAuthor>Ricour C</RefAuthor>
        <RefAuthor>Navarro J</RefAuthor>
        <RefTitle>Blood levels of water-soluble vitamins in pediatric patients on total parenteral nutrition using a multiple vitamin preparation</RefTitle>
        <RefYear>1989</RefYear>
        <RefJournal>JPEN J Parenter Enteral Nutr</RefJournal>
        <RefPage>176-84</RefPage>
        <RefTotal>Marinier E, Gorski AM, de Courcy GP, Criqui C, Bunodiere M, Christides JP, Causse MB, Brion F, Ricour C, Navarro J. Blood levels of water-soluble vitamins in pediatric patients on total parenteral nutrition using a multiple vitamin preparation. JPEN J Parenter Enteral Nutr. 1989;13(2):176-84. DOI: 10.1177&#47;0148607189013002176</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1177&#47;0148607189013002176</RefLink>
      </Reference>
      <Reference refNo="12">
        <RefAuthor>Silvers KM</RefAuthor>
        <RefAuthor>Sluis KB</RefAuthor>
        <RefAuthor>Darlow BA</RefAuthor>
        <RefAuthor>McGill F</RefAuthor>
        <RefAuthor>Stocker R</RefAuthor>
        <RefAuthor>Winterbourn CC</RefAuthor>
        <RefTitle>Limiting light-induced lipid peroxidation and vitamin loss in infant parenteral nutrition by adding multivitamin preparations to Intralipid</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Acta Paediatr</RefJournal>
        <RefPage>242-9</RefPage>
        <RefTotal>Silvers KM, Sluis KB, Darlow BA, McGill F, Stocker R, Winterbourn CC. Limiting light-induced lipid peroxidation and vitamin loss in infant parenteral nutrition by adding multivitamin preparations to Intralipid. Acta Paediatr. 2001;90(3):242-9. DOI: 10.1080&#47;080352501300067433</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1080&#47;080352501300067433</RefLink>
      </Reference>
      <Reference refNo="13">
        <RefAuthor>Anonym</RefAuthor>
        <RefTitle>Guidelines for essential trace element preparations for parenteral use. A statement by an expert panel. AMA Department of Foods and Nutrition</RefTitle>
        <RefYear>1979</RefYear>
        <RefJournal>JAMA</RefJournal>
        <RefPage>2051-4</RefPage>
        <RefTotal>Guidelines for essential trace element preparations for parenteral use. A statement by an expert panel. AMA Department of Foods and Nutrition. JAMA. 1979;241(19):2051-4.</RefTotal>
      </Reference>
      <Reference refNo="14">
        <RefAuthor>Greene HL</RefAuthor>
        <RefAuthor>Hambidge KM</RefAuthor>
        <RefAuthor>Schanler R</RefAuthor>
        <RefAuthor>Tsang RC</RefAuthor>
        <RefTitle>Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition</RefTitle>
        <RefYear>1988</RefYear>
        <RefJournal>Am J Clin Nutr</RefJournal>
        <RefPage>1324-42</RefPage>
        <RefTotal>Greene HL, Hambidge KM, Schanler R, Tsang RC. Guidelines for the use of vitamins, trace elements, calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: report of the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice Issues of the American Society for Clinical Nutrition. Am J Clin Nutr. 1988;48(5):1324-42.</RefTotal>
      </Reference>
      <Reference refNo="15">
        <RefAuthor>Mikalunas V</RefAuthor>
        <RefAuthor>Fitzgerald K</RefAuthor>
        <RefAuthor>Rubin H</RefAuthor>
        <RefAuthor>McCarthy R</RefAuthor>
        <RefAuthor>Craig RM</RefAuthor>
        <RefTitle>Abnormal vitamin levels in patients receiving home total parenteral nutrition</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>J Clin Gastroenterol</RefJournal>
        <RefPage>393-6</RefPage>
        <RefTotal>Mikalunas V, Fitzgerald K, Rubin H, McCarthy R, Craig RM. Abnormal vitamin levels in patients receiving home total parenteral nutrition. J Clin Gastroenterol. 2001;33(5):393-6. DOI: 10.1097&#47;00004836-200111000-00010</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1097&#47;00004836-200111000-00010</RefLink>
      </Reference>
      <Reference refNo="16">
        <RefAuthor>Steephen AC</RefAuthor>
        <RefAuthor>Traber MG</RefAuthor>
        <RefAuthor>Ito Y</RefAuthor>
        <RefAuthor>Lewis LH</RefAuthor>
        <RefAuthor>Kayden HJ</RefAuthor>
        <RefAuthor>Shike M</RefAuthor>
        <RefTitle>Vitamin E status of patients receiving long-term parenteral nutrition: is vitamin E supplementation adequate&#63; JPEN J Parenter Enteral Nutr.</RefTitle>
        <RefYear>1991</RefYear>
        <RefTotal>Steephen AC, Traber MG, Ito Y, Lewis LH, Kayden HJ, Shike M. Vitamin E status of patients receiving long-term parenteral nutrition: is vitamin E supplementation adequate&#63; JPEN J Parenter Enteral Nutr. 1991;15(6):647-52. DOI: 10.1177&#47;0148607191015006647</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1177&#47;0148607191015006647</RefLink>
      </Reference>
      <Reference refNo="17">
        <RefAuthor>Smith JL</RefAuthor>
        <RefAuthor>Canham JE</RefAuthor>
        <RefAuthor>Kirkland WD</RefAuthor>
        <RefAuthor>Wells PA</RefAuthor>
        <RefTitle>Effect of Intralipid, amino acids, container, temperature, and duration of storage on vitamin stability in total parenteral nutrition admixtures</RefTitle>
        <RefYear>1988</RefYear>
        <RefJournal>JPEN J Parenter Enteral Nutr</RefJournal>
        <RefPage>478-83</RefPage>
        <RefTotal>Smith JL, Canham JE, Kirkland WD, Wells PA. Effect of Intralipid, amino acids, container, temperature, and duration of storage on vitamin stability in total parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr. 1988;12(5):478-83. DOI: 10.1177&#47;0148607188012005478</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1177&#47;0148607188012005478</RefLink>
      </Reference>
      <Reference refNo="18">
        <RefAuthor>Jonas CR</RefAuthor>
        <RefAuthor>Puckett AB</RefAuthor>
        <RefAuthor>Jones DP</RefAuthor>
        <RefAuthor>Griffith DP</RefAuthor>
        <RefAuthor>Szeszycki EE</RefAuthor>
        <RefAuthor>Bergman GF</RefAuthor>
        <RefAuthor>Furr CE</RefAuthor>
        <RefAuthor>Tyre C</RefAuthor>
        <RefAuthor>Carlson JL</RefAuthor>
        <RefAuthor>Galloway JR</RefAuthor>
        <RefAuthor>Blumberg JB</RefAuthor>
        <RefAuthor>Ziegler TR</RefAuthor>
        <RefTitle>Plasma antioxidant  status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients</RefTitle>
        <RefYear>2000</RefYear>
        <RefJournal>Am J Clin Nutr</RefJournal>
        <RefPage>181-9</RefPage>
        <RefTotal>Jonas CR, Puckett AB, Jones DP, Griffith DP, Szeszycki EE, Bergman GF, Furr CE, Tyre C, Carlson JL, Galloway JR, Blumberg JB, Ziegler TR. Plasma antioxidant  status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am J Clin Nutr. 2000;72(1):181-9.</RefTotal>
      </Reference>
      <Reference refNo="19">
        <RefAuthor>Vollbracht C</RefAuthor>
        <RefAuthor>McGregor P</RefAuthor>
        <RefTitle>Vitamin C - ein f&#252;r die Intensivmedizin essenzieller Mikron&#228;hrstoff &#91;Vitamin C - an essential micro nutrient for the intensive care medicine&#93;</RefTitle>
        <RefYear>2004</RefYear>
        <RefBookTitle>Ernaehrung und Infusionstherapie</RefBookTitle>
        <RefPage>37-48</RefPage>
        <RefTotal>Vollbracht C, McGregor P. Vitamin C - ein f&#252;r die Intensivmedizin essenzieller Mikron&#228;hrstoff &#91;Vitamin C - an essential micro nutrient for the intensive care medicine&#93;. In: Hartig W, Biesalski HK, Druml W, Fuerst P, Weimann A, Hrsg. Ernaehrung und Infusionstherapie. Standards fuer Klinik, Intensivtherapie und Ambulanz. Stuttgart: Thieme; 2004. p. 37-48.</RefTotal>
      </Reference>
      <Reference refNo="20">
        <RefAuthor>Berger MM</RefAuthor>
        <RefAuthor>Chiol&#233;ro RL</RefAuthor>
        <RefTitle>Key vitamins and trace elements in the critically ill</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Nestle Nutr Workshop Ser Clin Perform Programme</RefJournal>
        <RefPage>99-111</RefPage>
        <RefTotal>Berger MM, Chiol&#233;ro RL. Key vitamins and trace elements in the critically ill. Nestle Nutr Workshop Ser Clin Perform Programme. 2003;8:99-111. DOI: 10.1159&#47;000072750</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1159&#47;000072750</RefLink>
      </Reference>
      <Reference refNo="21">
        <RefAuthor>Nathens AB</RefAuthor>
        <RefAuthor>Neff MJ</RefAuthor>
        <RefAuthor>Jurkovich GJ</RefAuthor>
        <RefAuthor>Klotz P</RefAuthor>
        <RefAuthor>Farver K</RefAuthor>
        <RefAuthor>Ruzinski JT</RefAuthor>
        <RefAuthor>Radella F</RefAuthor>
        <RefAuthor>Garcia I</RefAuthor>
        <RefAuthor>Maier RV</RefAuthor>
        <RefTitle>Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>Ann Surg</RefJournal>
        <RefPage>814-22</RefPage>
        <RefTotal>Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236(6):814-22. DOI: 10.1097&#47;00000658-200212000-00014</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1097&#47;00000658-200212000-00014</RefLink>
      </Reference>
      <Reference refNo="22">
        <RefAuthor>Young B</RefAuthor>
        <RefAuthor>Ott L</RefAuthor>
        <RefAuthor>Kasarskis E</RefAuthor>
        <RefAuthor>Rapp R</RefAuthor>
        <RefAuthor>Moles K</RefAuthor>
        <RefAuthor>Dempsey RJ</RefAuthor>
        <RefAuthor>Tibbs PA</RefAuthor>
        <RefAuthor>Kryscio R</RefAuthor>
        <RefAuthor>McClain C</RefAuthor>
        <RefTitle>Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury</RefTitle>
        <RefYear>1996</RefYear>
        <RefJournal>J Neurotrauma</RefJournal>
        <RefPage>25-34</RefPage>
        <RefTotal>Young B, Ott L, Kasarskis E, Rapp R, Moles K, Dempsey RJ, Tibbs PA, Kryscio R, McClain C. Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury. J Neurotrauma. 1996;13(1):25-34. DOI: 10.1089&#47;neu.1996.13.25</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1089&#47;neu.1996.13.25</RefLink>
      </Reference>
      <Reference refNo="23">
        <RefAuthor>Angstwurm MW</RefAuthor>
        <RefAuthor>Schottdorf J</RefAuthor>
        <RefAuthor>Schopohl J</RefAuthor>
        <RefAuthor>Gaertner R</RefAuthor>
        <RefTitle>Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome</RefTitle>
        <RefYear>1999</RefYear>
        <RefJournal>Crit Care Med</RefJournal>
        <RefPage>1807-13</RefPage>
        <RefTotal>Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999;27(9):1807-13. DOI: 10.1097&#47;00003246-199909000-00017</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1097&#47;00003246-199909000-00017</RefLink>
      </Reference>
      <Reference refNo="24">
        <RefAuthor>Berger MM</RefAuthor>
        <RefAuthor>Reymond MJ</RefAuthor>
        <RefAuthor>Shenkin A</RefAuthor>
        <RefAuthor>Rey F</RefAuthor>
        <RefAuthor>Wardle C</RefAuthor>
        <RefAuthor>Cayeux C</RefAuthor>
        <RefAuthor>Schindler C</RefAuthor>
        <RefAuthor>Chiol&#233;ro RL</RefAuthor>
        <RefTitle>Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Intensive Care Med</RefJournal>
        <RefPage>91-100</RefPage>
        <RefTotal>Berger MM, Reymond MJ, Shenkin A, Rey F, Wardle C, Cayeux C, Schindler C, Chiol&#233;ro RL. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med. 2001;27(1):91-100. DOI: 10.1007&#47;s001340000757</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1007&#47;s001340000757</RefLink>
      </Reference>
      <Reference refNo="25">
        <RefAuthor>Galley HF</RefAuthor>
        <RefAuthor>Davies MJ</RefAuthor>
        <RefAuthor>Webster NR</RefAuthor>
        <RefTitle>Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading</RefTitle>
        <RefYear>1996</RefYear>
        <RefJournal>Free Radic Biol Med</RefJournal>
        <RefPage>139-43</RefPage>
        <RefTotal>Galley HF, Davies MJ, Webster NR. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Radic Biol Med. 1996;20(1):139-43. DOI: 10.1016&#47;0891-5849(95)02022-5</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1016&#47;0891-5849(95)02022-5</RefLink>
      </Reference>
      <Reference refNo="26">
        <RefAuthor>Galley HF</RefAuthor>
        <RefAuthor>Howdle PD</RefAuthor>
        <RefAuthor>Walker BE</RefAuthor>
        <RefAuthor>Webster NR</RefAuthor>
        <RefTitle>The effects of intravenous antioxidants in patients with septic shock</RefTitle>
        <RefYear>1997</RefYear>
        <RefJournal>Free Radic Biol Med</RefJournal>
        <RefPage>768-74</RefPage>
        <RefTotal>Galley HF, Howdle PD, Walker BE, Webster NR. The effects of intravenous antioxidants in patients with septic shock. Free Radic Biol Med. 1997;23(5):768-74. DOI: 10.1016&#47;S0891-5849(97)00059-2</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1016&#47;S0891-5849(97)00059-2</RefLink>
      </Reference>
      <Reference refNo="27">
        <RefAuthor>Berger MM</RefAuthor>
        <RefAuthor>Cavadini C</RefAuthor>
        <RefAuthor>Chiolero R</RefAuthor>
        <RefAuthor>Guinchard S</RefAuthor>
        <RefAuthor>Krupp S</RefAuthor>
        <RefAuthor>Dirren H</RefAuthor>
        <RefTitle>Influence of large intakes of trace elements on recovery after major burns</RefTitle>
        <RefYear>1994</RefYear>
        <RefJournal>Nutrition</RefJournal>
        <RefPage>327-34</RefPage>
        <RefTotal>Berger MM, Cavadini C, Chiolero R, Guinchard S, Krupp S, Dirren H. Influence of large intakes of trace elements on recovery after major burns. Nutrition. 1994;10(4):327-34.</RefTotal>
      </Reference>
      <Reference refNo="28">
        <RefAuthor>Berger MM</RefAuthor>
        <RefAuthor>Spertini F</RefAuthor>
        <RefAuthor>Shenkin A</RefAuthor>
        <RefAuthor>Wardle C</RefAuthor>
        <RefAuthor>Wiesner L</RefAuthor>
        <RefAuthor>Schindler C</RefAuthor>
        <RefAuthor>Chiolero RL</RefAuthor>
        <RefTitle>Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial</RefTitle>
        <RefYear>1998</RefYear>
        <RefJournal>Am J Clin Nutr</RefJournal>
        <RefPage>365-71</RefPage>
        <RefTotal>Berger MM, Spertini F, Shenkin A, Wardle C, Wiesner L, Schindler C, Chiolero RL. Trace element supplementation modulates pulmonary infection rates after major burns: a double-blind, placebo-controlled trial. Am J Clin Nutr. 1998;68(2):365-71.</RefTotal>
      </Reference>
      <Reference refNo="29">
        <RefAuthor>Bertin-Maghit M</RefAuthor>
        <RefAuthor>Goudable J</RefAuthor>
        <RefAuthor>Dalmas E</RefAuthor>
        <RefAuthor>Steghens JP</RefAuthor>
        <RefAuthor>Bouchard C</RefAuthor>
        <RefAuthor>Gueugniaud PY</RefAuthor>
        <RefAuthor>Petit P</RefAuthor>
        <RefAuthor>Delafosse B</RefAuthor>
        <RefTitle>Time course of oxidative stress after major burns</RefTitle>
        <RefYear>2000</RefYear>
        <RefJournal>Intensive Care Med</RefJournal>
        <RefPage>800-3</RefPage>
        <RefTotal>Bertin-Maghit M, Goudable J, Dalmas E, Steghens JP, Bouchard C, Gueugniaud PY, Petit P, Delafosse B. Time course of oxidative stress after major burns. Intensive Care Med. 2000;26(6):800-3. DOI: 10.1007&#47;s001340051250</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1007&#47;s001340051250</RefLink>
      </Reference>
      <Reference refNo="30">
        <RefAuthor>Ritter C</RefAuthor>
        <RefAuthor>Andrades M</RefAuthor>
        <RefAuthor>Guerreiro M</RefAuthor>
        <RefAuthor>Zavaschi L</RefAuthor>
        <RefAuthor>Gelain DP</RefAuthor>
        <RefAuthor>Souza LF</RefAuthor>
        <RefAuthor>Ribeiro CA</RefAuthor>
        <RefAuthor>Clausell N</RefAuthor>
        <RefAuthor>Menna-Barreto S</RefAuthor>
        <RefAuthor>Moreira JC</RefAuthor>
        <RefAuthor>Dal-Pizzol F</RefAuthor>
        <RefTitle>Plasma oxidative parameters and mortality in patients with severe burn injury</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Intensive Care Med</RefJournal>
        <RefPage>1380-3</RefPage>
        <RefTotal>Ritter C, Andrades M, Guerreiro M, Zavaschi L, Gelain DP, Souza LF, Ribeiro CA, Clausell N, Menna-Barreto S, Moreira JC, Dal-Pizzol F. Plasma oxidative parameters and mortality in patients with severe burn injury. Intensive Care Med. 2003;29(8):1380-3. DOI: 10.1007&#47;s00134-003-1833-9</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1007&#47;s00134-003-1833-9</RefLink>
      </Reference>
      <Reference refNo="31">
        <RefAuthor>Laurent T</RefAuthor>
        <RefAuthor>Markert M</RefAuthor>
        <RefAuthor>Feihl F</RefAuthor>
        <RefAuthor>Schaller MD</RefAuthor>
        <RefAuthor>Perret C</RefAuthor>
        <RefTitle>Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine</RefTitle>
        <RefYear>1996</RefYear>
        <RefJournal>Chest</RefJournal>
        <RefPage>163-6</RefPage>
        <RefTotal>Laurent T, Markert M, Feihl F, Schaller MD, Perret C. Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine. Chest. 1996;109(1):163-6. DOI: 10.1378&#47;chest.109.1.163</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1378&#47;chest.109.1.163</RefLink>
      </Reference>
      <Reference refNo="32">
        <RefAuthor>Cross JM</RefAuthor>
        <RefAuthor>Donald AE</RefAuthor>
        <RefAuthor>Nuttall SL</RefAuthor>
        <RefAuthor>Deanfield JE</RefAuthor>
        <RefAuthor>Woolfson RG</RefAuthor>
        <RefAuthor>Macallister RJ</RefAuthor>
        <RefTitle>Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure</RefTitle>
        <RefYear>2003</RefYear>
        <RefJournal>Kidney Int</RefJournal>
        <RefPage>1433-42</RefPage>
        <RefTotal>Cross JM, Donald AE, Nuttall SL, Deanfield JE, Woolfson RG, Macallister RJ. Vitamin C improves resistance but not conduit artery endothelial function in patients with chronic renal failure. Kidney Int. 2003;63(4):1433-42. DOI: 10.1046&#47;j.1523-1755.2003.00852.x</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1046&#47;j.1523-1755.2003.00852.x</RefLink>
      </Reference>
      <Reference refNo="33">
        <RefAuthor>Ambrose ML</RefAuthor>
        <RefAuthor>Bowden SC</RefAuthor>
        <RefAuthor>Whelan G</RefAuthor>
        <RefTitle>Working memory impairments in alcohol-dependent participants without clinical amnesia</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Alcohol Clin Exp Res</RefJournal>
        <RefPage>185-91</RefPage>
        <RefTotal>Ambrose ML, Bowden SC, Whelan G. Working memory impairments in alcohol-dependent participants without clinical amnesia. Alcohol Clin Exp Res. 2001;25(2):185-91. DOI: 10.1111&#47;j.1530-0277.2001.tb02197.x</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1111&#47;j.1530-0277.2001.tb02197.x</RefLink>
      </Reference>
      <Reference refNo="34">
        <RefAuthor>Hung SC</RefAuthor>
        <RefAuthor>Hung SH</RefAuthor>
        <RefAuthor>Tarng DC</RefAuthor>
        <RefAuthor>Yang WC</RefAuthor>
        <RefAuthor>Chen TW</RefAuthor>
        <RefAuthor>Huang TP</RefAuthor>
        <RefTitle>Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients</RefTitle>
        <RefYear>2001</RefYear>
        <RefJournal>Am J Kidney Dis</RefJournal>
        <RefPage>941-7</RefPage>
        <RefTotal>Hung SC, Hung SH, Tarng DC, Yang WC, Chen TW, Huang TP. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 2001;38(5):941-7. DOI: 10.1053&#47;ajkd.2001.28578</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1053&#47;ajkd.2001.28578</RefLink>
      </Reference>
      <Reference refNo="35">
        <RefAuthor>Thomson AD</RefAuthor>
        <RefAuthor>Cook CC</RefAuthor>
        <RefAuthor>Touquet R</RefAuthor>
        <RefAuthor>Henry JA; Royal College of Physicians</RefAuthor>
        <RefAuthor>London</RefAuthor>
        <RefTitle>The Royal College of Physicians report on alcohol: guidelines for managing Wernicke&#39;s encephalopathy in the accident and Emergency Department</RefTitle>
        <RefYear>2002</RefYear>
        <RefJournal>Alcohol Alcohol</RefJournal>
        <RefPage>513-21</RefPage>
        <RefTotal>Thomson AD, Cook CC, Touquet R, Henry JA; Royal College of Physicians, London. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke&#39;s encephalopathy in the accident and Emergency Department. Alcohol Alcohol. 2002;37(6):513-21. DOI: 10.1093&#47;alcalc&#47;37.6.513</RefTotal>
        <RefLink>http:&#47;&#47;dx.doi.org&#47;10.1093&#47;alcalc&#47;37.6.513</RefLink>
      </Reference>
    </References>
    <Media>
      <Tables>
        <Table format="png">
          <MediaNo>1</MediaNo>
          <MediaID>1</MediaID>
          <Caption>
            <Pgraph>
              <Mark1>Table 1: Standard daily doses of parenterally administered electrolytes in PN in adult patients (adapted from &#91;5&#93;)</Mark1>
            </Pgraph>
          </Caption>
        </Table>
        <Table format="png">
          <MediaNo>2</MediaNo>
          <MediaID>2</MediaID>
          <Caption>
            <Pgraph>
              <Mark1>Table 2: Estimated daily requirements of parenterally administered vitamins and trace elements in adult patients (adapted from &#91;5, 7&#93;) </Mark1>
            </Pgraph>
          </Caption>
        </Table>
        <Table format="png">
          <MediaNo>3</MediaNo>
          <MediaID>3</MediaID>
          <Caption>
            <Pgraph>
              <Mark1>Table 3: Estimated daily requirements of parenterally administered vitamins and trace elements in infants and children (according to &#91;13, 14&#93;)</Mark1>
            </Pgraph>
          </Caption>
        </Table>
        <Table format="png">
          <MediaNo>4</MediaNo>
          <MediaID>4</MediaID>
          <Caption>
            <Pgraph>
              <Mark1>Table 4: Risk constellations for potentially increased requirements of vitamins and trace elements</Mark1>
            </Pgraph>
          </Caption>
        </Table>
        <Table format="png">
          <MediaNo>5</MediaNo>
          <MediaID>5</MediaID>
          <Caption>
            <Pgraph>
              <Mark1>Table 5: Vitamin supplements for parenteral administration available in Germany</Mark1>
            </Pgraph>
          </Caption>
        </Table>
        <Table format="png">
          <MediaNo>6</MediaNo>
          <MediaID>6</MediaID>
          <Caption>
            <Pgraph>
              <Mark1>Table 6: Trace element supplements for parenteral application available in Germany</Mark1>
            </Pgraph>
          </Caption>
        </Table>
        <NoOfTables>6</NoOfTables>
      </Tables>
      <Figures>
        <NoOfPictures>0</NoOfPictures>
      </Figures>
      <InlineFigures>
        <NoOfPictures>0</NoOfPictures>
      </InlineFigures>
      <Attachments>
        <NoOfAttachments>0</NoOfAttachments>
      </Attachments>
    </Media>
  </OrigData>
</GmsArticle>
